Hepatitis C: Community Testing and Treatment (CT2 Study Myanmar)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
Implementation-effectiveness hybrid trial assessing acceptability, feasibility and cost-effectiveness of community-based point-of-care testing and treatment for hepatitis C. Utilises Cepheid GeneXpert HCV VL device as diagnostic tool (diagnosis of chronic infection and assessment of treatment outcome) and sofosbuvir/daclatasvir for HCV therapy (local standard of care).
Epistemonikos ID: d7998e2a1556e5259998ee050a6c1669609287f5
First added on: May 22, 2024